Src-dependent phosphorylation of μ-opioid receptor at Tyr336 modulates opiate withdrawal

EMBO Mol Med. 2017 Nov;9(11):1521-1536. doi: 10.15252/emmm.201607324.

Abstract

Opiate withdrawal/negative reinforcement has been implicated as one of the mechanisms for the progression from impulsive to compulsive drug use. Increase in the intracellular cAMP level and protein kinase A (PKA) activities within the neurocircuitry of addiction has been a leading hypothesis for opiate addiction. This increase requires the phosphorylation of μ-opioid receptor (MOR) at Tyr336 by Src after prolonged opiate treatment in vitro Here, we report that the Src-mediated MOR phosphorylation at Tyr336 is a prerequisite for opiate withdrawal in mice. We observed the recruitment of Src in the vicinity of MOR and an increase in phosphorylated Tyr336 (pY336) levels during naloxone-precipitated withdrawal. The intracerebroventricular or stereotaxic injection of a Src inhibitor (AZD0530), or Src shRNA viruses attenuated pY336 levels, and several somatic withdrawal signs. This was also observed in Fyn-/- mice. The stereotaxic injection of wild-type MOR, but not mutant (Y336F) MOR, lentiviruses into the locus coeruleus of MOR-/- mice restored somatic withdrawal jumping. Regulating pY336 levels during withdrawal might be a future target for drug development to prevent opiate addictive behaviors.

Keywords: Src‐mediated phosphorylation of MOR at Tyr336; lentivirus injection; locus coeruleus; naloxone‐precipitated opiate withdrawal; opiate addiction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Benzodioxoles / pharmacology
  • Body Weight / drug effects
  • HEK293 Cells
  • Humans
  • Locomotion / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Morphine / pharmacology
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-fyn / antagonists & inhibitors
  • Proto-Oncogene Proteins c-fyn / deficiency
  • Proto-Oncogene Proteins c-fyn / genetics
  • Proto-Oncogene Proteins c-fyn / metabolism
  • Quinazolines / pharmacology
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Receptors, Opioid, mu / deficiency
  • Receptors, Opioid, mu / genetics
  • Receptors, Opioid, mu / metabolism*
  • Tyrosine / chemistry
  • Tyrosine / metabolism*
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / genetics
  • src-Family Kinases / metabolism*

Substances

  • Benzodioxoles
  • Narcotic Antagonists
  • Quinazolines
  • RNA, Small Interfering
  • Receptors, Opioid, mu
  • Naloxone
  • Tyrosine
  • Morphine
  • saracatinib
  • Fyn protein, mouse
  • Proto-Oncogene Proteins c-fyn
  • src-Family Kinases